BSE filing, NSE: SANOFICONR. Summary written from the filing by ALFA Finder's alert engine.
Sanofi Consumer Healthcare India Ltd: key numbers
- Share price
- ₹3,333.00
- Market cap
- ₹7,676 Cr
- Revenue (annual)
- ₹878.4 Cr
- Net profit (annual)
- ₹240.1 Cr
- P/E (TTM)
- 28.9×Sector 46.5×
- Promoter holding
- 71.27%+0.00% QoQ
- FII holding
- 2.48%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sanofi Consumer Healthcare India Ltd
All →Sanofi Consumer Healthcare India Q2 FY27 Results: Net Profit ₹76.6 Cr, Up 21.8% YoY
Sanofi Consumer Healthcare India Ltd reported revenue from operations of ₹263.1 Cr (+12.5% YoY) and net profit of ₹76.6 Cr (+21.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹76.6 Cr · +21.8% YoY
Sanofi Consumer Healthcare India Other Announcement
Sanofi Consumer Healthcare India Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. The disclosure provides details of shareholding across various investor categories.
Sanofi Consumer Healthcare India Q1 FY27 Results: Net Profit ₹68.8 Cr, Up 13.3% YoY
Sanofi Consumer Healthcare India Ltd reported revenue from operations of ₹235.7 Cr (+6.7% YoY) and net profit of ₹68.8 Cr (+13.3% YoY) for Q1 FY27.
- Key figure
- Net profit ₹68.8 Cr · +13.3% YoY
Sanofi Consumer Healthcare India Board Meeting Date
Sanofi Consumer Healthcare India Limited will hold a board meeting on 28th July 2026 to consider and approve its unaudited financial results.
Sanofi Consumer Healthcare India Other Announcement
The company filed its quarterly shareholding pattern for the period ending June 30, 2026, detailing the distribution of equity among promoter and public shareholders.
Sanofi Consumer Healthcare India Management Change
Sanofi Consumer Healthcare India appointed PwC as Statutory Auditor. The term spans five consecutive years until the 8th AGM in 2031.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.